InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Panacea Innovation Ltd. Officer active across 2 companies, notably Atara Biotherapeutics, Inc.. In total, 5 reports have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €1.2m. History available since 17 July 2025. The latest transaction was disclosed on 17 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Panacea Innovation Ltd is a declarant linked to Atara Biotherapeutics, Inc. on XNAS. The record shows 5 filings in total, and across the 5 sampled filings between 2025-07-21 and 2026-03-19, the reported amounts are EUR 735855 in buys and EUR 420708 in sells, with Levée d'options as the modal transaction nature.